These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 32826317)

  • 1. Csx3 is a cyclic oligonucleotide phosphodiesterase associated with type III CRISPR-Cas that degrades the second messenger cA
    Brown S; Gauvin CC; Charbonneau AA; Burman N; Lawrence CM
    J Biol Chem; 2020 Oct; 295(44):14963-14972. PubMed ID: 32826317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetramerisation of the CRISPR ring nuclease Crn3/Csx3 facilitates cyclic oligoadenylate cleavage.
    Athukoralage JS; McQuarrie S; Grüschow S; Graham S; Gloster TM; White MF
    Elife; 2020 Jun; 9():. PubMed ID: 32597755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis of cyclic oligoadenylate degradation by ancillary Type III CRISPR-Cas ring nucleases.
    Molina R; Jensen ALG; Marchena-Hurtado J; López-Méndez B; Stella S; Montoya G
    Nucleic Acids Res; 2021 Dec; 49(21):12577-12590. PubMed ID: 34850143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis of cyclic oligoadenylate binding to the transcription factor Csa3 outlines cross talk between type III and type I CRISPR systems.
    Xia P; Dutta A; Gupta K; Batish M; Parashar V
    J Biol Chem; 2022 Feb; 298(2):101591. PubMed ID: 35038453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Type III-B Cmr effector complex catalyzes the synthesis of cyclic oligoadenylate second messengers by cooperative substrate binding.
    Han W; Stella S; Zhang Y; Guo T; Sulek K; Peng-Lundgren L; Montoya G; She Q
    Nucleic Acids Res; 2018 Nov; 46(19):10319-10330. PubMed ID: 30239876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of the cyclic oligoadenylate signaling pathway of type III CRISPR systems.
    Rouillon C; Athukoralage JS; Graham S; Grüschow S; White MF
    Methods Enzymol; 2019; 616():191-218. PubMed ID: 30691643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An anti-CRISPR viral ring nuclease subverts type III CRISPR immunity.
    Athukoralage JS; McMahon SA; Zhang C; Grüschow S; Graham S; Krupovic M; Whitaker RJ; Gloster TM; White MF
    Nature; 2020 Jan; 577(7791):572-575. PubMed ID: 31942067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR-Cas III-A Csm6 CARF Domain Is a Ring Nuclease Triggering Stepwise cA
    Jia N; Jones R; Yang G; Ouerfelli O; Patel DJ
    Mol Cell; 2019 Sep; 75(5):944-956.e6. PubMed ID: 31326273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR antiphage defence mediated by the cyclic nucleotide-binding membrane protein Csx23.
    Grüschow S; McQuarrie S; Ackermann K; McMahon S; Bode BE; Gloster TM; White MF
    Nucleic Acids Res; 2024 Apr; 52(6):2761-2775. PubMed ID: 38471818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of cyclic oligoadenylate synthesis by the
    Nasef M; Muffly MC; Beckman AB; Rowe SJ; Walker FC; Hatoum-Aslan A; Dunkle JA
    RNA; 2019 Aug; 25(8):948-962. PubMed ID: 31076459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation and self-inactivation mechanisms of the cyclic oligoadenylate-dependent CRISPR ribonuclease Csm6.
    Garcia-Doval C; Schwede F; Berk C; Rostøl JT; Niewoehner O; Tejero O; Hall J; Marraffini LA; Jinek M
    Nat Commun; 2020 Mar; 11(1):1596. PubMed ID: 32221291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ring nucleases deactivate type III CRISPR ribonucleases by degrading cyclic oligoadenylate.
    Athukoralage JS; Rouillon C; Graham S; Grüschow S; White MF
    Nature; 2018 Oct; 562(7726):277-280. PubMed ID: 30232454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Type III CRISPR Ancillary Ribonuclease Degrades Its Cyclic Oligoadenylate Activator.
    Athukoralage JS; Graham S; Grüschow S; Rouillon C; White MF
    J Mol Biol; 2019 Jul; 431(15):2894-2899. PubMed ID: 31071326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis of cyclic tetra-oligoadenylate processing by small standalone CRISPR-Cas ring nucleases.
    Molina R; Garcia-Martin R; López-Méndez B; Jensen ALG; Ciges-Tomas JR; Marchena-Hurtado J; Stella S; Montoya G
    Nucleic Acids Res; 2022 Oct; 50(19):11199-11213. PubMed ID: 36271789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic Tetra-Adenylate (cA
    Charbonneau AA; Eckert DM; Gauvin CC; Lintner NG; Lawrence CM
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type III CRISPR-Cas systems produce cyclic oligoadenylate second messengers.
    Niewoehner O; Garcia-Doval C; Rostøl JT; Berk C; Schwede F; Bigler L; Hall J; Marraffini LA; Jinek M
    Nature; 2017 Aug; 548(7669):543-548. PubMed ID: 28722012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cyclic oligonucleotide signaling pathway in type III CRISPR-Cas systems.
    Kazlauskiene M; Kostiuk G; Venclovas Č; Tamulaitis G; Siksnys V
    Science; 2017 Aug; 357(6351):605-609. PubMed ID: 28663439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition of a pseudo-symmetric RNA tetranucleotide by Csx3, a new member of the CRISPR associated Rossmann fold superfamily.
    Topuzlu E; Lawrence CM
    RNA Biol; 2016; 13(2):254-7. PubMed ID: 26727591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of Oligonucleotide Signaling Mediated by CRISPR-Associated Polymerases Solves Two Puzzles but Leaves an Enigma.
    Koonin EV; Makarova KS
    ACS Chem Biol; 2018 Feb; 13(2):309-312. PubMed ID: 28937734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzymatic properties of CARF-domain proteins in
    Ding J; Schuergers N; Baehre H; Wilde A
    Front Microbiol; 2022; 13():1046388. PubMed ID: 36419420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.